For example, SMARCD3 transcription is reduced in ER+ breast tumor cells due to methylation of the SMARCD3 promoter, but in ER+ breast cancer, SMARCD3 is still regarded as a tumor suppressor gene [29]. This evidence concerns the gene SMARCD3 and breast carcinoma.